Dr. Pablo V. Uceda, MD

Dr. Uceda practices at Methodist Southwest Medical Center in Dallas, Texas, part of Methodist Hospitals of Dallas.

Dr. Uceda's NPI, 1508813916, was assigned on May 30, 2006. Dr. Uceda graduated from National University of San Marcos in 1983. Dr. Uceda's Texas license number on file is J4675.

Dr. Uceda's primary practice is Methodist Southwest Medical Center, at 3500 W Wheatland Road, Dallas, TX 75237 in Dallas County. The practice phone is (214) 947-7777.

Dr. Uceda's primary practice is Methodist Southwest Medical Center in Dallas, Texas, part of Methodist Hospitals of Dallas. Dr. Uceda is also affiliated with Methodist Dallas Medical Center. The medical group on file is DFW Vascular Group. Dmand AI also links Dr. Uceda to 1 more breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uceda practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Uceda's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Uceda is board certified in surgery by the American Board of Surgery. Dr. Uceda has a license on file in Texas.

Dmand AI lists acute mini-stroke (TIA), aortic atherosclerois, cerebrovascular disease, chronic kidney disease, deep vein thrombosis (DVT), peripheral vascular disease and varicose veins among the conditions Dr. Uceda treats.

CMS data shows 895 Medicare services from Dr. Uceda across 18 procedure codes in 2024, for 151 Medicare patients. Medicare paid $152,651 for them.

CMS counts 151 Medicare patients who saw Dr. Uceda in 2024. The largest group is under 65, with 65 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 7.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uceda's median patient age at 67, with 51% women.

In 2024, Dr. Uceda wrote 304 Medicare Part D claims for 127 patients. 81% of them were for generic drugs. CMS names the drug for 266 of them, across 6 drugs with 11 or more claims each, at $47,097 in total drug cost. In 2023, CMS named 374 claims across 6 drugs.

Dr. Uceda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Uceda, published from 2016 to 2021. 2020 was the busiest year, with 3. The most frequent topics are Arteriovenous Shunt, Surgical, Blood Vessel Prosthesis and Blood Vessel Prosthesis Implantation. Dr. Uceda has published most often in Ann Vasc Surg. Dr. Uceda's most frequent co-authors are Sam S. Ahn, MD, Robert Warren Feldtman, MD and Sam Seunghae Ahn, MD.

CMS Open Payments shows 144 general payments to Dr. Uceda from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $652.

Dmand AI lists 1 award for Dr. Uceda, most recently CMS Stage 1 EHR in 2013.

Dr. Uceda graduated from National University of San Marcos in 1983. Dr. Uceda is a member of Dallas County Medical Society and TMA.

Dr. Uceda is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.